| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-27 | 2,898.21 | 648.18 | 127.24p | 28.9 | 2.5 | +12% | 27.27p | 0.0% |
| 31-Mar-28 | 3,148.13 | 708.15 | 140.44p | 26.2 | 2.5 | +10% | 29.70p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
|---|---|---|---|---|---|---|
| Revenue (£m) | ||||||
| 31-Mar-2027 | 2,898 | 2,895 | n/a | n/a | n/a | n/a |
| 31-Mar-2028 | 3,148 | 3,138 | n/a | n/a | n/a | n/a |
| Earnings | ||||||
| 31-Mar-2027 | 127.24p | 126.78p | n/a | n/a | n/a | n/a |
| 31-Mar-2028 | 140.44p | 139.83p | n/a | n/a | n/a | n/a |
| Dividend | ||||||
| 31-Mar-2027 | 27.27p | 27.30p | n/a | n/a | n/a | n/a |
| 31-Mar-2028 | 29.70p | 29.79p | n/a | n/a | n/a | n/a |
| Recommendations | ||||||
| Strong Buy | 5 | 5 | 0 | 0 | 4 | 0 |
| Buy | 5 | 5 | 0 | 0 | 4 | 0 |
| Neutral | 2 | 2 | 0 | 0 | 9 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 0 |
| No. of Brokers | 12 | 12 | 0 | 0 | 18 | 0 |
| Average Rec | 8.12 | 8.12 | n/a | n/a | 6.39 | n/a |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 3,676.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 4,878.00 |
| 52 Week Low | 3,208.00 |
| Volume | 1,372,696 |
| Shares Issued | 377.70m |
| Market Cap | £13,884m |
| RiskGrade | 112 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 5 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 12 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 09-Jul-26 | 18-Dec-25 |
| Paid | 14-Aug-26 | 30-Jan-26 |
| Amount | 15.11p | 9.63p |
| Time | Volume / Share Price |
| 16:29 | 1 @ 3,672.00p |
| 16:29 | 44 @ 3,672.00p |
| 16:29 | 146 @ 3,674.00p |
| 16:29 | 459 @ 3,674.00p |
| 16:29 | 182 @ 3,674.00p |
| CFO | Carole Cran |
| CEO | Marc Ronchetti |
| Chair | Dame Louise Makin |
You are here: research